Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity-Reference-Cited by-同舟云学术

Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity

Published:2016-09 Issue:1 Volume:511 Page:236-244
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Teymouri Manouchehr,Badiee Ali,Golmohammadzadeh Shiva,Sadri Kayvan,Akhtari Javad,Mellat Mostafa,Nikpoor Amin Reza,Jaafari Mahmoud Reza

Funder

Biotechnology Research Center and Nanotechnology Research Center

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 Affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors;Akhtari;Int. J. Pharm.,2016

2. Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models;Alavizadeh;Expert Opin. Drug Deliv.,2016

3. Use of the post-insertion method for the formation of ligand-coupled liposomes;Allen;Cell. Mol. Biol. Lett.,2002

4. Doxil®⿿the first FDA-approved nano-drug: lessons learned;Barenholz;J. Control. Release,2012

5. Phosphorus assay in column chromatography;Bartlett;J. Biol. Chem.,1959

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of m2 peptide targeted nanoliposomes containing crocin on induction of phenotypic change in tumor macrophages to M1 state;Life Sciences;2023-10

2. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin;Pharmaceutics;2023-03-09

3. Development, Characterization, and In Vitro Biological Performance of Amphotericin B and Terbinafine Microemulsions Against Leishmania major;Current Microbiology;2022-11-03

4. Therapeutic silencing of mTOR by systemically administered siRNA-loaded neutral liposomal nanoparticles inhibits DMBA-induced mammary carcinogenesis;British Journal of Cancer;2022-10-19

5. pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation;Journal of Pharmaceutical Sciences;2021-12